29 reports

  • 4.3.4 RESOLUTION PHASE
  • Opportunities

Like asthma, not to use a beta blocker.

  • Pain Relief
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.

Asthma Small Molecules to Block Cav##. ## Channel for Chronic Pain Small Molecules to Block Cav##. ## for Neuropathic Pain Small Molecules to Block HCN## Channel for Chronic Neuropathic Pain Small Molecules to Block Nav ##. ## Channels for Chronic And Neuropathic Pain Small Molecules to Block Nav ##. ##

  • Pain Relief
  • World
  • Market Size
  • Allergan plc
  • Amgen Inc.
  • Treatment of Migraine - Pharmacological (Preventive)

Vernalis possess high-value drug development programs in partnership development which includes candidates in oncology, asthma & allergic rhinitis.

  • Clinical Trial
  • Pain Relief
  • World
  • Forecast
  • Allergan plc

THE DRUG IN THIS FORM WAS MARKETED UNDER DIFFERENT BRAND NAMES INCLUDING ADRENALINE, ADRENALINE CHLORIDE AND ASTHMA NEFRIN.

  • Injectable Delivery
  • Neurological Disorder
  • Pain Relief
  • Demand
  • Market Size

ARNUITY ELLIPTA, WHICH IS A ONCE-DAILY INHALED CORTICOSTEROID MEDICINE TO TREAT ASTHMA, WAS APPROVED FOR ASTHMA TREATMENT.

  • Pain Relief
  • Canada
  • North America
  • Mylan Inc.
  • Pfizer Inc.
  • PERCENTAGE OF MIGRAINE SUFFERERS WORLDWIDE BY GENDER
  • Disease overview

ACCORDING TO THE MIGRAINE TRUST, MIGRAINES ARE MORE PREVALENT THAN DIABETES, EPILEPSY, AND ASTHMA WITH A TOTAL OF EIGHT MILLION PEOPLE SUFFERING FROM MIGRAINES IN THE UK.

  • Pain Relief
  • Allergan plc
  • Endo International plc
  • Impax Laboratories, Inc.
  • Pfizer Inc.

The panel expressed concerns over side-effects and the possibility for off-label use for use in asthma patients.

  • Pain Relief
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • CAPNIA, INC. PIPELINE PRODUCTS SUMMARY BY DEVELOPMENT STAGE

United States Early development Class II ##(k) September, 2021 DIAGNOSTIC DEVICE - ASTHMA - PRODUCT DESCRIPTION Technology Indication Application Sensalyze Technology Asthma Asthma Management DIAGNOSTIC DEVICE - BLOOD CO## DIAGNOSTIC DEVICE - BLOOD CO## PRODUCT OVERVIEW DIA

  • Pain Relief
  • China
  • United States
  • Company
  • Capnia, Inc.
  • DORMANT PROJECTS (CONTD..4), H1 2016
  • DORMANT PRODUCTS, H1 2018 (CONTD..3), H1 2018

Neurim offers treatments for other therapeutic areas that include Parkinson' s disease, and asthma or chronic obstructive pulmonary disease.

  • Pain Relief
  • R&D
  • Research And Development
  • Therapy
  • Flex Pharma, Inc.
  • DORMANT PRODUCTS, H2 2017 (CONTD..3), H2 2017

Neurim offers treatments for other therapeutic areas that include Parkinson" s disease, and asthma or chronic obstructive pulmonary disease.

  • Neurology
  • Pain Relief
  • United States
  • Product Initiative
  • Flex Pharma, Inc.
  • participate in a long-term safety study.
  • BHV-3500 - Drug Profile
  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • Amgen Inc.
  • apparent total body clearance (CLT/F) will be derived from plasma concentration versus time.
  • OTC
  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • Calcitonin Gene Related Peptide (CGRP) - Dormant Products
  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • Teva Pharmaceutical Industries Ltd.
  • BHV-3500 - DRUG PROFILE
  • apparent total body clearance (CLT/F) will be derived from plasma concentration versus time.

Migraine - Pipeline Review, H## 2017 Reference Code: GMDHC##IDB Publication Date: October 2017 LIST OF TABLES Introduction GLOBAL MARKETS DIRECT REPORT COVERAGE Global Markets Direct' s, ' Migraine - Pipeline Review, H## 2017', provides an overview of the Migraine pipeline landscape.

  • Antimigraine
  • Pain Relief
  • Pharmaceutical
  • United States
  • Product Initiative
  • UBROGEPANT - DRUG PROFILE
  • Allergan, USD 150 million for reimbursement of expenses associated with the transaction.

ZOLMITRIPTAN - DRUG PROFILE In December 2016, a special population study to evaluate safe inhalation in patients with asthma and in smokers was completed.

  • Pain Relief
  • Pharmaceutical
  • United States
  • Product Initiative
  • Allergan plc

The company' s pipeline candidate HX-## is developed to treat diabetic neuropathy and allergic asthma.

  • Pain Relief
  • United States
  • Company
  • Product Initiative
  • Pfizer Inc.
  • Calcitonin Gene Related Peptide (CGRP) - Dormant Projects
  • OTC
  • Pain Relief
  • Therapy
  • United States
  • Product Initiative
  • PAIN RELIEF DEVICE - PRODUCT STATUS
  • PAIN RELIEF DEVICE - PRODUCT DESCRIPTION

Presented post approval study results at the American Thoracic Society International Conference that demonstrated the Alair™ Bronchial Thermoplasty System reduced complications, including severe asthma exacerbations and asthma-related hospitalizations, in adult patients with severe

  • Clinical Trial
  • Drug Discovery And Development
  • Pain Relief
  • United States
  • GlobalData's company
  • Other Developmental Activities

It was under development for the treatment of asthma and seasonal allergic rhinitis.

  • Pain Relief
  • Therapy
  • United States
  • M&A
  • Allergan plc

asthma.

  • Healthcare
  • Pain Relief
  • Pharmaceutical
  • Company
  • Recordati S.p.A.

asthma.

  • Healthcare
  • Pain Relief
  • Pharmaceutical
  • Company
  • Recordati S.p.A.

Hence, the OX-CLI and OX-ESI programs, focusing on discovering and developing innovative new treatments for asthma, chronic obstructive pulmonary disease and other inflammatory diseases, will be closed.

  • Health Services
  • Pain Relief
  • Pharmaceutical
  • United States
  • Johnson & Johnson

Hence, the OX-CLI and OX-ESI programs, focusing on discovering and developing innovative new treatments for asthma, chronic obstructive pulmonary disease and other inflammatory diseases, will be closed.

  • Health Services
  • Pain Relief
  • Pharmaceutical
  • United States
  • Johnson & Johnson

The company' s products include aldara, atopiclai, benziq targeting dermatology conditions including actinic keratosis, superficial basal cell carcinoma, external genital warts, atopic dermatitis, and acne; maxair autohaler targeting respiratory conditions including Asthma; Estrasorb fo

  • Healthcare
  • Immunology
  • Pain Relief
  • Pharmaceutical
  • Perrigo Company

The poster presentation, reported on the cardiac effects of nVNS in asthma patients using nVNS to treat acute bronchospasm.

  • Clinical Trial
  • Hospital
  • Pain Relief
  • Therapy
  • GlobalData's company
  • 5. All the trials included are unique trials.

Asthma Compared to Healthy Volunteers A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder GDCT## NCT##, TRIP-PK-##; GDC## Central Nervous System Migraine Completed Phase I Interventional zolmitriptan Acorda Therapeutics Inc ## Sep 2016 ##

  • Clinical Trial
  • Hormone
  • Pain Relief
  • Pharmaceutical
  • World
  • Drug Details

asthma Relevant allergy or known hypersensitivity to the investigational drugs, its excipients and/ or to other NSAIDs Participation in another clinical trial within the last ## weeks and concurrent participation in another clinical trial Patients with active gastroesophageal flux diseas

  • Pain Relief
  • World
  • Market Size
  • Product Initiative
  • Tonix Pharmaceuticals Holding Corp.

Asthma, Rheumatic Disorders Completed Phase IV Interventional acetaminophen University of Texas Southwestern Medical Center at Dallas McNEIL-PPC, Inc. ## Nov 2006 ## Oct 2008 ## ## ## ## COX-## Inhibitor; COX-## Inhibitor Prostaglandin G/ H Synthase ## (Cyclooxygenase-## or COX-## or Prostagla

  • Musculoskeletal Disorder
  • Pain Relief
  • Pharmaceutical
  • World
  • Product Initiative

asthma.

  • Healthcare
  • Pain Relief
  • Pharmaceutical
  • Company
  • Recordati S.p.A.